Antibodies, NeutralizingAnti-Retroviral AgentsHIV Antibodies
Dr. Paul A. Volberding, MD
NPI1356457881
- Part D claims, 2018
- 35
- Publications
- 202
- Clinical trials
- 3
- Industry payments
- $70,777
- Insurance carriers
- 3
- Practice address
- 4150 Clement St, San Francisco, CA 94121-1545
- Practice phone
- Call (415) 750-2037
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Volberding's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Paul A. Volberding is a hematologist and oncologist in San Francisco, California
Dr. Volberding practices in San Francisco, California.
Dr. Volberding's NPI, 1356457881, was assigned on August 21, 2006. Dr. Volberding graduated from University Of Minnesota Medical School in 1975. Dr. Volberding holds California license G36568.
NPI and contact details
- NPI
- 1356457881NPI Registry (opens in a new tab)
- NPI enumeration date
- August 21, 2006
- NPI status
- Active
- Practice phone
- (415) 750-2037
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Medical school graduation
- 1975
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. Paul A. Volberding's practice address is in San Francisco, California
Dr. Volberding's practice address in the NPI Registry is 4150 Clement St, San Francisco, CA 94121-1545. The practice phone is (415) 750-2037.
- NPI Registry address4150 Clement St, San Francisco, CA 94121-1545Phone(415) 750-2037
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Paul A. Volberding's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Volberding practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Volberding's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Volberding practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Paul A. Volberding is one of 1,502 hematologists and oncologists in California
Hematology and oncology is Dr. Volberding's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Volberding is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Volberding's licenses on file in 2 states: California and Utah.
Specialties and state licenses
- Hematology and oncology, CaliforniaPrimary
- Utah license
Hematologists and oncologists near Dr. Volberding
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Paul A. Volberding wrote 35 Medicare Part D claims in 2018
In 2018, Dr. Volberding wrote 35 Medicare Part D claims. They cover 3 drugs, with $39,746 in total drug cost. In 2016, CMS named 55 claims across 4 drugs.
Part D claims, 201835
Drugs named by CMS3
Total drug cost$39,746
Dr. Volberding's most prescribed drugs by claims, 2018
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2016 to 2018
- 2016
- 2018
- Claims for drugs CMS names
- 2016: 552018: 3536%
Drugs named by CMS: 3 in 2018, 4 in 2016.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Volberding by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Paul A. Volberding has 202 publications on record
Dmand AI links 202 papers to Dr. Volberding, published from 2007 to 2023. 2016 was the busiest year, with 3. The most frequent topics are Acquired Immunodeficiency Syndrome, HIV Infections and Sarcoma, Kaposi. Dr. Volberding has published most often in JAMA. Dr. Volberding's most frequent co-authors are Donald Ira Abrams, MD, Lawrence D. Kaplan, MD and Margaret A. Fischl, MD.
Papers202
Years published2007 to 2023
Dr. Volberding's papers by year, 2007 to 2023
Topics Dr. Volberding writes about most
- Acquired Immunodeficiency Syndrome
- HIV Infections
- Sarcoma, Kaposi
- Zidovudine
- AIDS-Related Complex
- CD4 Lymphocyte Count
- Homosexuality
- Anti-HIV Agents
Dr. Volberding's most frequent co-authors
- Donald Ira Abrams, MD23 shared papers
- Lawrence D. Kaplan, MD18 shared papers
- Margaret A. Fischl, MD10 shared papers
Recent publications by Dr. Volberding
HIV-1HIV InfectionsInterferons
HIV InfectionsHIV SerosortingHomosexuality, Male
Drug Alcohol Depend
Alcohol DrinkingContinuity of Patient CareDelivery of Health Care, Integrated
See who Dr. Volberding researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Volberding works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Paul A. Volberding has worked on 3 clinical trials
Dmand AI links Dr. Volberding to 3 clinical trials, 2 of them phase 2 studies. Conditions studied include HIV Infections, Lentivirus Infections and Hepatitis C, Chronic. National Institute of Allergy and Infectious Diseases (NIAID) sponsors the most, 2.
Clinical trials with Dr. Volberding by phase
- NonePhase 1: no trials
- 2Phase 2: 2 trials
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Volberding's trials
- HIV Infections
- Lentivirus Infections
- Hepatitis C, Chronic
- Hepatitis, Chronic
Investigators on the most trials with Dr. Volberding
- Raymond T. Chung, MD1 shared trial
- Stephen E. Follansbee, MD1 shared trial
- Joseph Clayton Gathe, MD1 shared trial
Recent clinical trials with Dr. Volberding
Hepatitis C, ChronicHepatitis, ChronicInterferon alfa-2aPeginterferon alfa-2aRibavirin
HIV InfectionsLentivirus InfectionsEfavirenzRitonavirSaquinavir
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV (opens in a new tab)
CompletedPhase 2
HIV InfectionsLentivirus InfectionsAbacavir sulfateAmprenavirLamivudine
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Paul A. Volberding received $70,777 in industry payments from 2016 to 2025
CMS Open Payments shows 56 general payments to Dr. Volberding from 2 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $63,027.
General payments to Dr. Volberding by program year, 2016 to 2025
General payments to Dr. Volberding by kind, 2016 to 2025
$70.8Kin total
- Consulting fees$70,770100%
- Food and beverage$70%
Companies that paid Dr. Volberding the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Paul A. Volberding has 33 awards and honors on record
Dmand AI lists 33 awards for Dr. Volberding, most recently 150th Anniversary Alumni Excellence Award in 2015.
Awards and honors for Dr. Volberding
- 2015
- 150th Anniversary Alumni Excellence Award
- Master
- 2014
- America's Top Doctors
- Mentor of the Year Award
- 2013
- America's Top Doctors for Cancer
- 2009
- Sydney Rosen Service Award
Source: Dmand AI Professional Profile Data
Dr. Paul A. Volberding graduated from University Of Minnesota Medical School
Dr. Volberding graduated from University Of Minnesota Medical School in 1975.
- Medical school
- Board certified in internal medicine
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Paul A. Volberding accepts plans from 3 insurance carriers
Dr. Volberding is in network with 3 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.
- Blue Cross Blue Shield of Michigan
- Blue Cross Blue Shield of Massachusetts
- HCSC
Plan types Dr. Volberding accepts, by number of carriers
- Medicare3
- PPO3
- HMO1
- POS1
Source: Dmand AI Insurance Network Data
Sources for Dr. Paul A. Volberding's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Paul A. Volberding
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Paul A. Volberding's NPI number?
Dr. Paul A. Volberding's NPI number is 1356457881. It was assigned on August 21, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Paul A. Volberding?
Dr. Paul A. Volberding is a hematologist and oncologist in San Francisco, California. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Paul A. Volberding practice?
Dr. Volberding practices at 4150 Clement St, San Francisco, CA 94121-1545.
What is Dr. Paul A. Volberding's office phone number?
The practice phone on file for Dr. Volberding is (415) 750-2037.
What is Dr. Paul A. Volberding's medical license number?
Dr. Volberding holds California license G36568, one of the licenses on file in 2 states.
Which states has Dr. Paul A. Volberding been licensed in?
Dmand AI has state licenses on file for Dr. Volberding in California (1978 to 2027) and Utah (1976 to 1982).
Is Dr. Paul A. Volberding board certified?
Yes. Dr. Volberding is board certified in internal medicine by the American Board of Internal Medicine.
Where did Dr. Paul A. Volberding go to medical school?
Dr. Volberding graduated from University Of Minnesota Medical School in 1975.
What drugs does Dr. Paul A. Volberding prescribe most?
In 2018 Medicare Part D data, Dr. Volberding's most prescribed drugs by claims were Descovy, Ventolin Hfa and Tivicay.
Has Dr. Paul A. Volberding received payments from drug or device companies?
CMS Open Payments shows $70,777 in general payments to Dr. Volberding from 2 companies from 2016 to 2025. The largest total came from Merck Sharp & Dohme Corporation.
Show 4 more questionsShow fewer questions
How long has Dr. Paul A. Volberding been practicing?
Dr. Volberding graduated from medical school in 1975, 51 years ago.
Does Dr. Paul A. Volberding do research?
Dmand AI links 202 publications to Dr. Volberding, published from 2007 to 2023. Dr. Volberding has worked on 3 clinical trials.
Who does Dr. Paul A. Volberding publish with?
Dr. Volberding's most frequent co-authors are Donald Ira Abrams, MD (23 shared papers), Lawrence D. Kaplan, MD (18 shared papers) and Margaret A. Fischl, MD (10 shared papers).
What insurance does Dr. Paul A. Volberding accept?
Dr. Volberding is in network with 3 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card